Clinical Trial Update: Glutamine PET Imaging Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating glutamine PET imaging in colorectal cancer (RAS wild-type), terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: RAS Wild Type, Stage IV Colorectal Cancer | Phase 1 | Status: TERMINATED